13F-HR filed by Velan Capital Investment Management LP
Velan Capital Investment Management LP filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 27 holding rows worth $128,852,000.
- Accession
- 0001848809-22-000002
- Filer
- CIK 1848809
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 27 entries on the cover page, a total value of $128,852,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $128,852,000 with VALUE read as thousands by filing date, 13F file number 028-21996. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| JASPER THERAPEUTICS INC | 471871103 | COM | 3,219,036 | $22,945,000 | thousands by filing date | |
| LANTHEUS HLDGS INC | 516544103 | COM | 621,753 | $17,962,000 | thousands by filing date | |
| SCIENCE 37 HOLDINGS INC | 808644108 | COM | 1,200,000 | $14,964,000 | thousands by filing date | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 293,385 | $10,046,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 150,000 | $7,851,000 | thousands by filing date | call |
| ADMA BIOLOGICS INC | 000899104 | COM | 5,397,798 | $7,611,000 | thousands by filing date | |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 600,000 | $5,850,000 | thousands by filing date | |
| 9 METERS BIOPHARMA INC | 654405109 | COM | 4,328,306 | $4,236,000 | thousands by filing date | |
| NYXOAH S A | B6S7WD106 | SHS | 177,679 | $4,087,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 110,000 | $4,040,000 | thousands by filing date | |
| TELA BIO INC | 872381108 | COM | 300,000 | $3,840,000 | thousands by filing date | |
| CARIBOU BIOSCIENCES INC COM | 142038108 | Stock | 210,695 | $3,179,000 | thousands by filing date | |
| CONFORMIS INC | 20717E101 | COM | 4,166,607 | $3,172,000 | thousands by filing date | |
| SOMALOGIC INC | 83444K105 | COM | 235,300 | $2,739,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 400,000 | $2,572,000 | thousands by filing date | |
| SONIDA SENIOR LIVING INC | 140475203 | COMMON STOCK | 82,832 | $2,360,000 | thousands by filing date | |
| HEALTHCARE SVCS GROUP INC | 421906108 | COM | 123,000 | $2,188,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 747,768 | $1,997,000 | thousands by filing date | |
| RADIUS HEALTH INC | 750469207 | COM NEW | 275,281 | $1,905,000 | thousands by filing date | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 300,000 | $1,434,000 | thousands by filing date | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 446,500 | $1,308,000 | thousands by filing date | call |
| CURIS INC | 231269200 | COM | 250,000 | $1,190,000 | thousands by filing date | |
| GRAF ACQUISITION CORP IV | 384272100 | COM | 86,506 | $836,000 | thousands by filing date | |
| ENVVENO MEDICAL CORPORATION | 29415J106 | COM | 74,478 | $491,000 | thousands by filing date | |
| GRAF ACQUISITION CORP IV | 384272118 | *W EXP 05/31/202 | 20,000 | $23,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 1,125 | $19,000 | thousands by filing date | |
| SOMALOGIC INC | 83444k113 | WT | 2,060 | $7,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001848809-22-000002 | this filing | 2022-02-14 | acceptance time not in the bulk data set |